- Home
- ADAP vs CBFV Comparison
ADAP vs CBFV Comparison
Compare ADAP & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- CBFV
- Stock Information
- Founded
- ADAP 2008
- CBFV 1901
- Country
- ADAP United Kingdom
- CBFV United States
- Employees
- ADAP N/A
- CBFV N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- CBFV Major Banks
- Sector
- ADAP Health Care
- CBFV Finance
- Exchange
- ADAP Nasdaq
- CBFV Nasdaq
- Market Cap
- ADAP 158.6M
- CBFV 148.0M
- IPO Year
- ADAP 2015
- CBFV N/A
- Fundamental
- Price
- ADAP $0.58
- CBFV $28.28
- Analyst Decision
- ADAP Strong Buy
- CBFV Hold
- Analyst Count
- ADAP 4
- CBFV 2
- Target Price
- ADAP $2.79
- CBFV $26.00
- AVG Volume (30 Days)
- ADAP 2.3M
- CBFV 7.9K
- Earning Date
- ADAP 03-05-2025
- CBFV 01-29-2025
- Dividend Yield
- ADAP N/A
- CBFV 3.54%
- EPS Growth
- ADAP N/A
- CBFV 62.63
- EPS
- ADAP N/A
- CBFV 4.36
- Revenue
- ADAP $175,041,000.00
- CBFV $67,214,000.00
- Revenue This Year
- ADAP $204.91
- CBFV N/A
- Revenue Next Year
- ADAP N/A
- CBFV $0.21
- P/E Ratio
- ADAP N/A
- CBFV $6.48
- Revenue Growth
- ADAP 146.27
- CBFV 24.04
- 52 Week Low
- ADAP $0.53
- CBFV $20.75
- 52 Week High
- ADAP $2.05
- CBFV $33.72
- Technical
- Relative Strength Index (RSI)
- ADAP 41.87
- CBFV 44.20
- Support Level
- ADAP $0.55
- CBFV $26.53
- Resistance Level
- ADAP $0.65
- CBFV $28.65
- Average True Range (ATR)
- ADAP 0.05
- CBFV 0.50
- MACD
- ADAP 0.00
- CBFV 0.04
- Stochastic Oscillator
- ADAP 31.31
- CBFV 71.14
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.